Investor Outlook: Netflix shares fall as weak forecast raises growth concerns
Netflix shares drop after weak forecast as analysts warn growth may rely too heavily on frequent price increases.
ADVERTISEMENT
Netflix shares drop after weak forecast as analysts warn growth may rely too heavily on frequent price increases.
Savaria targets $1.6B revenue by 2030, driven by aging demographics, home accessibility demand and a mix of organic growth and acquisitions.
Morgan Stanley shares rise on strong trading and wealth results as banks post record equity trading revenue.
Johnson & Johnson beats earnings and raises forecast as drug growth and new therapies drive strong quarterly results.
Geopolitical tensions disrupt LNG flows and raise concerns about European gas supply and global energy security
BlackBerry shares climb after earnings beat, with growth driven by QNX automotive software and secure communications demand.
Fast-food chains focus on core menu upgrades as Canadian consumers remain selective, prioritizing quality, value and consistency.
Broadcom’s deal with Google highlights rising AI infrastructure demand and growing competition to Nvidia as enterprise adoption accelerates.
Event industry investment signals strong demand for in-person gatherings, premium experiences and customized event design in Canada.
Maritime Launch secures a $200M defence deal to advance its Nova Scotia spaceport and support future orbital launch operations.
Porter Airlines launches operations at Montreal Metropolitan Airport as expansion accelerates with new routes and growing fleet.
Metatek begins trading on TSX after IPO, as strong demand for energy and mineral exploration drives backlog and expansion plans.
Canadians raised over $1 billion online in five years, reflecting strong giving trends and growing adoption of digital fundraising platforms.
Dollarama shares face pressure after missing comparable sales estimates, with weaker traffic and softer guidance weighing on near-term performance.
Canadian hormone health platform raises $10M to expand personalized care and address gaps in treatment across age groups.
Desjardins completes $1.67B Guardian deal as executives warn of volatility and expect more consolidation in asset management.